Prestige Consumer Healthcare Inc. Quarterly Debt-to-equity in % from Q4 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Prestige Consumer Healthcare Inc. quarterly Debt-to-equity history and growth rate from Q4 2011 to Q3 2024.
  • Prestige Consumer Healthcare Inc. Debt-to-equity for the quarter ending September 30, 2024 was 99.2 %, a 20.1% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 99.2 -24.9 -20.1% Sep 30, 2024
Q2 2024 105 -21.2 -16.7% Jun 30, 2024
Q1 2024 113 -15.6 -12.1% Mar 31, 2024
Q4 2023 121 -7.97 -6.2% Dec 31, 2023
Q3 2023 124 -9.08 -6.82% Sep 30, 2023
Q2 2023 127 -12.5 -8.99% Jun 30, 2023
Q1 2023 128 -15.6 -10.9% Mar 31, 2023
Q4 2022 128 -20.4 -13.7% Dec 31, 2022
Q3 2022 133 -21.1 -13.7% Sep 30, 2022
Q2 2022 139 -19.3 -12.2% Jun 30, 2022
Q1 2022 144 -21.9 -13.2% Mar 31, 2022
Q4 2021 149 -28.5 -16% Dec 31, 2021
Q3 2021 154 -32.6 -17.5% Sep 30, 2021
Q2 2021 158 -39.3 -19.9% Jun 30, 2021
Q1 2021 166 -40.4 -19.6% Mar 31, 2021
Q4 2020 177 -32.3 -15.4% Dec 31, 2020
Q3 2020 187 -22.1 -10.6% Sep 30, 2020
Q2 2020 198 -10.9 -5.23% Jun 30, 2020
Q1 2020 206 -5.06 -2.4% Mar 31, 2020
Q4 2019 210 -2.85 -1.34% Dec 31, 2019
Q3 2019 209 -9.45 -4.33% Sep 30, 2019
Q2 2019 209 -35.6 -14.6% Jun 30, 2019
Q1 2019 211 -61.3 -22.5% Mar 31, 2019
Q4 2018 212 -98.9 -31.8% Dec 31, 2018
Q3 2018 218 -112 -33.9% Sep 30, 2018
Q2 2018 244 -69 -22% Jun 30, 2018
Q1 2018 272 -24.1 -8.13% Mar 31, 2018
Q4 2017 311 +36.2 +13.1% Dec 31, 2017
Q3 2017 330 +50.6 +18.1% Sep 30, 2017
Q2 2017 313 +29.1 +10.2% Jun 30, 2017
Q1 2017 297 +10.9 +3.81% Mar 31, 2017
Q4 2016 275 -15.8 -5.42% Dec 31, 2016
Q3 2016 280 -30 -9.7% Sep 30, 2016
Q2 2016 284 -44.4 -13.5% Jun 30, 2016
Q1 2016 286 -24.1 -7.77% Mar 31, 2016
Q4 2015 291 +6.03 +2.12% Dec 31, 2015
Q3 2015 310 +49.2 +18.9% Sep 30, 2015
Q2 2015 329 +101 +44.3% Jun 30, 2015
Q1 2015 310 +74.5 +31.7% Mar 31, 2015
Q4 2014 285 +38.6 +15.6% Dec 31, 2014
Q3 2014 260 +5.4 +2.12% Sep 30, 2014
Q2 2014 228 -45.5 -16.6% Jun 30, 2014
Q1 2014 235 -55.9 -19.2% Mar 31, 2014
Q4 2013 246 -63 -20.3% Dec 31, 2013
Q3 2013 255 -27 -9.58% Sep 30, 2013
Q2 2013 273 +25.5 +10.3% Jun 30, 2013
Q1 2013 291 +79.3 +37.4% Mar 31, 2013
Q4 2012 309 +135 +77.4% Dec 31, 2012
Q3 2012 282 Sep 30, 2012
Q2 2012 248 Jun 30, 2012
Q1 2012 212 Mar 31, 2012
Q4 2011 174 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.